- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Melissa Andel Previews Her Upcoming Session on Drug Pricing Reform at AMCP 2022
Melissa Andel, principal at CommonHealth Solutions, previewed her session on policy making and pricing reform at the upcoming Academy of Managed Care Pharmacy's annual meeting.
Melissa Andel, principal at CommonHealth Solutions, previewed her session on policy making and pricing reform at the upcoming Academy of Managed Care Pharmacy's annual meeting.
Transcript
What will you be talking about during your session at AMCP 2022?
So, my session is just going to be an update on what's going on here in [Washington,] DC, mainly with regard to Congress, as well as what the Biden administration has been working on with respect to drug price reform. So, not just reconciliation, but also some of the administrative rules that HHS has, which also includes CMS and HRSA [Health Resources and Services Administration], and some of the actions that the Biden administration has been working on and what that means for patients and payers and manufacturers.
What other presentations are you looking forward to checking out at AMCP 2022?
Oh, yeah, so I've got a couple. I was filling out my agenda the other day. But yeah, there's a couple on digital therapeutics that I'm looking forward to and also a few on value-based purchasing contracts and 340B and the Medicaid pharmacy benefit that I'm looking forward to attending. So, the sessions that are on some of the newer trends that are facing payers and the industry are always interesting to me.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
